Crossmark

Discovery of novel indoleamine 2,3-dioxygenase-1 (IDO-1) inhibitors: pharmacophore-based 3D-QSAR, Gaussian field-based 3D-QSAR, docking, and binding free energy studies

Crossref DOI link: https://doi.org/10.1007/s11224-023-02213-0

Published Online: 2023-08-03

Published Print: 2024-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Tabti, Kamal

Sbai, Abdelouahid

Maghat, Hamid

Lakhlifi, Tahar

Bouachrine, Mohammed
License Information

Text and Data Mining valid from 2023-08-03

Version of Record valid from 2023-08-03
More Information

Article History

Received: 27 April 2023

Accepted: 24 July 2023

First Online: 3 August 2023

Declarations

:

: This chapter does not contain any studies with human participants or animals performed by any of the authors.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below